Estrace combined with Medroxyprogesterone Acetate

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Female Other Serious 12/12/2003 Female 1/3/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/2/1998 68 Female 12/30/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/14/2002 54 Female 1/31/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 2/1/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious Female 1/27/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 Female 2/3/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 2/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1998 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/14/1999 64 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/22/2002 73 Female 2/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/9/2002 64 Female 2/22/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 3/3/2006 Lawyer United States
Primary
Secondary
Metastases To Lymph Nodes Other Serious Female 2/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/24/2000 Female 3/1/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/1997 56 Female 3/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/13/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/17/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 3/17/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 4/11/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 4/6/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 4/11/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 64 Female 4/12/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/4/2002 Female 4/25/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/24/2002 Female 5/1/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/24/2002 Female 4/25/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/4/2002 Female 4/26/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 5/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 Female 5/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/24/2002 Female 4/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 5/11/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/17/1998 59 Female 5/24/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/31/2000 Female 6/1/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/30/1996 66 Female 5/30/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/4/2005 57 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/16/1999 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/31/2000 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/13/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 60 Female 6/9/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 6/23/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 6/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/4/2002 Female 6/29/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/3/2001 Female 7/3/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/4/2002 Female 6/29/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 6/28/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 56 Female 6/30/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 6/4/2002 Female 7/3/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 Female 7/17/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/20/2000 Female 7/19/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 Female 7/20/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/1999 Female 7/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 7/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/20/2000 Female 7/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2000 Female 7/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/28/2000 Female 7/25/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/1/1999 Female 7/25/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 7/25/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 7/19/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/20/2000 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/28/2000 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 11/28/2000 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/1999 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2000 Female 7/21/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 5/4/2000 Female 8/7/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2001 55 Female 8/8/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 70 Female 192 lb 8/15/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 70 Female 8/9/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 55 Female 8/14/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 9/17/1999 68 Female 8/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 51 Female 8/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/1998 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/28/2001 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/27/2002 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/15/2002 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2003 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/24/2002 Female 9/5/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/24/2002 Female 9/1/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2005 Female 9/21/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/3/2001 Female 9/25/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2002 Female 10/4/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2002 Female 10/13/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 12/27/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/24/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2001 Female 2/22/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/22/2003 Female 3/16/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2001 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 1/31/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/26/2001 Female 5/8/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/16/2001 Female 5/24/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Required Intervention 8/1/1999 Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Required Intervention 4/24/2002 Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/20/1997 Female 7/27/2007 Other Health Professional United States
Primary
Secondary
Breast Cancer Required Intervention 6/21/2002 55 Female 137 lb 7/5/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/1/2003 57 Female 8/10/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/18/2003 Female 8/15/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 6/8/2000 Female 194 lb 8/15/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 8/21/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 Female 8/21/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2001 Female 8/21/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 8/21/2007 Consumer United States
Primary
Secondary
Somatisation Disorder Other Serious 3/20/1997 53 Female 8/31/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 9/8/2000 Female 9/24/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/1/2002 66 Female 10/12/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/6/1998 Female 10/29/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/23/2000 Female 10/30/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 6/27/1995 Female 11/20/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/9/2000 Female 12/10/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/1999 Female 12/27/2007 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/1999 55 Female 1/8/2008 Lawyer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/27/2001 57 Female 139 lb 1/10/2008 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Recurrent Other Serious 12/3/1996 Female 1/18/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/16/1998 53 Female 142 lb 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 4/23/2003 53 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2003 12/18/2007 United States
Primary
Secondary
Deep Vein Thrombosis Hospitalization 9/28/2001 52 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 2/22/2001 57 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/18/2007 United States
Primary
Secondary
Pulmonary Embolism Other Serious 11/5/2001 58 Female 12/18/2007 United States
Primary
Secondary
Vaginal Haemorrhage Other Serious 5/3/2001 55 Female 2/8/2008 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2004 Female 2/11/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/19/2003 Female 154 lb 2/20/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/24/2000 Female 2/20/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 Female 1/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/1/1998 Female 3/14/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/12/2000 Female 4/8/2008 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 5/25/2006 Physician United States
Primary
Secondary
Concomitant
Metastases To Lymph Nodes Other Serious 2/13/2002 Female 4/14/2008 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 2/22/2002 Female 5/1/2008 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 8/1/1999 Female 5/2/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/24/2000 Female 5/7/2008 Consumer United States
Primary
Secondary
Smear Cervix Abnormal Other Serious 1/1/1997 Female 5/8/2008 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 4/17/2002 Female 5/16/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/13/2000 Female 5/16/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/13/2002 Female 5/16/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/28/2000 Female 5/16/2008 Lawyer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Breast Cancer Recurrent Other Serious 12/3/1996 Female 5/22/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/18/2003 Female 6/3/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/8/2000 Female 122 lb 6/11/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/8/2000 Female 122 lb 6/12/2008 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 2/27/1997 Female 6/18/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 6/24/2008 Consumer United States
Primary
Secondary

Drug Data